Rheumatoid Arthritis Clinical Trials in New York

Showing 1681-1700 of 3,596 trials

Navitoclax and Vistusertib in Treating Patients With Relapsed Small Cell Lung Cancer and Other Solid Tumors

NCT03366103

This phase I/II trial studies the best dose and side effects of navitoclax and how well it works when given together with vistusertib in treating patients with small cell lung cancer and solid tumors that have come back (relapsed). Drugs used in chemotherapy, such as navitoclax, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Vistusertib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving navitoclax and vistusertib may work better than navitoclax alone in treating patients with small cell lung cancer and solid tumors.

Metastatic Malignant Solid NeoplasmRecurrent Lung Small Cell CarcinomaRecurrent Malignant Solid Neoplasm+6 more

National Cancer Institute (NCI)15 participantsStarted Mar 2018

Los Angeles, California, United States • Los Angeles, California, United States • Baltimore, Maryland, United States +11 more locations

COMPLETEDPhase 1< 1 mile

Entinostat in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors

NCT02780804

This phase I trial studies the side effects and best dose of entinostat in treating pediatric patients with solid tumors that have come back or have not responded to treatment. Entinostat may block some of the enzymes needed for cell division and it may help to kill tumor cells.

Brain Stem NeoplasmPineal Region NeoplasmRecurrent Lymphoma+7 more

National Cancer Institute (NCI)21 participantsStarted Jan 2017

Birmingham, Alabama, United States • Los Angeles, California, United States • Orange, California, United States +18 more locations

Navitoclax and Vistusertib in Treating Patients With Relapsed Small Cell Lung Cancer and Other Solid Tumors

Entinostat in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors

Rheumatoid Arthritis Trials in Other Cities

In-Stent Restenosis Post-Approval Study

Safety and Tolerability Study of ISIS EIF4E Rx in Combination With Docetaxel and Prednisone (CRPC)

Collecting and Storing Biological Samples From Patients With Ewing Sarcoma

Electrocardiographic Diagnostic Performance of the Apple Watch Augmented With an Artificial Intelligence Algorithm

Collecting and Storing Tissue Samples From Patients With Rare or Cutaneous Non-Hodgkin Lymphoma

Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis

Emotional Processing Intervention for Children With TBI

A Trial of Two Fixed Doses of ZX008 (Fenfluramine HCl) in Children and Young Adults With Dravet Syndrome

Long-Term Follow-up Safety of Clonidine Micropellets

Treatment of Pain Associated With Lumbosacral Radiculopathy in Adults

SeeMe: An Automated Tool to Detect Early Recovery After Brain Injury

Multimechanistic Treatment Over Time of Migraine Symptoms (MOVEMENT)

Clinical Survey Study to Assess Physical Function and the Incidence of Hypoglycemia in Participants With Glycogen Storage Disease Type III

Avatrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Adults With Active Non-Hematological Cancers

Treatment of Muscle Injury Following Arthroplasty for Hip Fracture (HF)

Use of a Tonometer to Identify Epileptogenic Lesions During Pediatric Epilepsy Surgery

An Extension Study to Evaluate the Long-Term Safety and Tolerability of UTTR1147A in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease

A Phase 1 Study to Evaluate FN-1501 Monotherapy in Patients With Advanced Solid Tumors and R/R AML

Other Conditions in New York